Venezia applicator with oblique needles improves clinical target volume coverage in distal parametrial tumor residue compared to parallel needles only

CONCLUSIONS: VeneziaTM applicator permits reproducible application to increase CTV coverage in patients with distal parametrial tumor residue during brachytherapy, while maintaining acceptable dose to OARs.PMID:34025733 | PMC:PMC8117708 | DOI:10.5114/jcb.2021.103583

Source: Journal of Contemporary Brachytherapy - May 24, 2021 Category: Cancer & Oncology Authors: Manon Kissel Nathalie Fournier-Bidoz Olivier Henry Sophie Bockel Tamizhanban Kumar Sophie Espenel Cyrus Chargari Source Type: research